Beijing Wantai Biological Pharmacy Enterprise Co Ltd (SHSE:603392) Share Price

Company Profile

Business description
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is engaged in research, development, production, and sales of in vitro diagnostic reagents, instruments, and vaccines. The company has two segments: Diagnostic and Vaccine. The Diagnostic segment develops and sells in vitro diagnostic reagents such as ELISA, colloidal gold, biochemical, and chemiluminescent kits, along with instruments including chemiluminescent analyzers, fluorescent analyzers, and nucleic acid purification systems. The Vaccine segment focuses on products like the hepatitis E vaccine, the bivalent HPV vaccine, and the nasal spray COVID-19 vaccine. It generates the majority of its revenue from the Diagnostic segment.
Contact
No. 31, Science Park Road
Changping District
Beijing102206
CHN
T: +86 1059528888
https://www.ystwt.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
3,790

Recommended

Consumer defensive names look undervalued.

Shani Jayamanne | 01 October 2025

Earnings outlook is strong and the shares trade at a discount to our fair value.

Morningstar | 01 October 2025

Our capital allocation rating was also lowered due to balance sheet weakness.

Esther Holloway | 01 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,240.30	42.60	0.46%
CAC 40	8,047.89	80.94	1.02%
DAX 40	24,393.86	280.24	1.16%
Dow JONES (US)	46,441.10	43.21	0.09%
FTSE 100	9,446.00	0.43	-0.00%
HKSE	27,287.12	431.56	1.61%
NASDAQ	22,755.16	95.15	0.42%
Nikkei 225	44,936.73	385.88	0.87%
NZX 50 Index	13,451.76	17.77	0.13%
S&P 500	6,711.20	22.74	0.34%
S&P/ASX 200	8,945.90	40.10	0.45%
SSE Composite Index	3,882.78	20.25	0.52%